-
公开(公告)号:US20170045495A1
公开(公告)日:2017-02-16
申请号:US15039806
申请日:2014-11-28
Inventor: Stephen Trowell , Amalia Berna , Benjamin Padovan , Vicki Locke
IPC: G01N33/497 , G01N33/50
CPC classification number: G01N33/497 , A61B5/082 , A61B5/4244 , A61B5/4848 , C12Q1/04 , C12Q1/18 , G01N33/5082 , G01N33/5088 , G01N2033/4975 , G01N2333/445 , G01N2560/00 , G01N2800/26 , G01N2800/52
Abstract: The present invention relates to a method of identifying a subject with a Plasmodium infection. The present invention also relates to a method for monitoring a subject with a Plasmodium infection, for example, following treatment with an anti-malaria compound. Also provided are methods of identifying a compound to treat a Plasmodium infection.
Abstract translation: 本发明涉及用疟原虫感染鉴定受试者的方法。 本发明还涉及一种用疟原虫感染来监测受试者的方法,例如用抗疟疾化合物处理之后。 还提供鉴定化合物以治疗疟原虫感染的方法。
-
公开(公告)号:US10101319B2
公开(公告)日:2018-10-16
申请号:US15039806
申请日:2014-11-28
Inventor: Stephen Trowell , Amalia Berna , Benjamin Padovan , Vicki Locke
Abstract: The present invention relates to a method of identifying a subject with a Plasmodium infection. The present invention also relates to a method for monitoring a subject with a Plasmodium infection, for example, following treatment with an anti-malaria compound. Also provided are methods of identifying a compound to treat a Plasmodium infection.
-
公开(公告)号:US10701931B2
公开(公告)日:2020-07-07
申请号:US15768456
申请日:2016-10-14
Applicant: Commonwealth Scientific and Industrial Research Organisation , The Council of the Queensland Institute of Medical Research
Inventor: Amalia Berna , Stephen Trowell , James McCarthy , Maggy Sikulu
IPC: A01N31/02 , A01P17/00 , A01P19/00 , A01M1/00 , A01M1/02 , A01M1/04 , A01M1/06 , A01M1/20 , A01M1/10
Abstract: The present invention relates to formulations useful for affecting the behaviour of mosquitoes. More specifically, the present invention relates to formulations for activating mosquitoes such as for attracting mosquitoes. The present invention further provides methods and dispensers incorporating these formulations. The formulation comprises a thio compound as the active, preferably a thioether such as allyl methyl sulphide (AMS), 1-methylthio-propane, 3-methylthio-propanol (MTPL), (E)-1-methylthio-1-propene, (Z)-1-methylthio-1-propene, or derivatives thereof.
-
-